November
What about our daughters? Women's health begins in childhood
The term “women’s health” implies a separation between what a female does during adulthood to stay healthy from what she did – or had done for her – as a child. However, more attention than ever is focusing on urging and enabling children to adopt healthy habits that will last a lifetime.
Growing without cell division
An international team of scientists, including biologists from the University of North Carolina at Chapel Hill, may have pinpointed for the first time the mechanism responsible for cell polyploidy, a state in which cells contain more than 2 paired sets of chromosomes.
Surgical bypass procedure in the skull does not reduce risk of stroke recurrence
A multi-center clinical trial led by Dr. William Powers of UNC finds that the surgical procedure did not lower the risk of subsequent stroke for people who’ve had a minor stroke.
Elderly emergency patients less likely to receive pain medication than middle-aged patients
A study by UNC researchers finds that people 75 years old or older are less likely to receive any pain medication in hospital emergency departments than people between 35 and 54 years old.
No evidence for potential competition between human papillomavirus types in men
One of the first-ever, UNC-led epidemiological studies to examine HPV-type competition in men found little evidence for potential type competition. Their findings are published in the online edition of the Journal of Infectious Diseases.
Avoiding nasty germs and flaming turkeys on Thanksgiving
Thanksgiving can be a time of great joy, but you should use caution in preparing the holiday meal. UNC’s experts offer preparation, cooking and nutrition tips to help you avoid common health and safety hazards.
Martha Jean Greene: Living the bountiful life in spite of aggressive cancer
A life-long resident of Watauga County is the model for how to live life to the fullest despite an aggressive cancer that is as tough a fighter as she is.
Study: Mycophenolate is superior to azathioprine as treatment for lupus nephritis
An international study finds that the immunosuppressant drug mycophenolate mofetil is superior to azathioprine, an older immunosuppressant, as a maintenance therapy for lupus nephritis. Dr. Mary Anne Dooley of UNC is first author of the study.
Scarring a necessary evil to prevent further damage after heart attack
Researchers have long sought ways to avoid scarring of the heart after a heart attack. But now new research from the University of North Carolina at Chapel Hill School of Medicine shows that interrupting this process can weaken heart function even further.
Salts of the earth
Elizabeth Swaringen, who writes our Family House Diaries stories, shares additional insights about the couple featured in the latest installment.
Protein associated with childhood cancer alters the structure of DNA, leading to cancer, UNC study shows
This laboratory discovery by UNC scientists could result in the development of a targeted therapy to treat Ewing Sarcoma, a malignant bone and soft tissue tumor of children and young adults.
P Rex-1 protein key to melanoma metastasis
Researchers from UNC Lineberger Comprehensive Cancer Center are part of a team that has identified a protein, called P-Rex1, that is key to the movement of cells called melanoblasts. When these cells experience uncontrolled growth, melanoma develops.
UNC tapped as training center for the state’s HIV health care providers
The University of North Carolina at Chapel Hill School of Medicine has been selected as the new home of the North Carolina AIDS Training and Education Center.
Cell molecule identified as central player in the formation of new blood vessels
The molecule is the protein Shc (pronounced SHIK), and new blood vessel formation, or angiogenesis, is seriously impaired without it.
Clinical trial for muscular dystrophy demonstrates safety of customized gene therapy
Researchers at the University of North Carolina at Chapel Hill have shown that it is safe to cut and paste together different viruses in an effort to create the ultimate vehicle for gene therapy.
